Powered by

Intec Pharma Reports Fourth Quarter and Year End 2017 Financial Results and Business Update

Mar 09, 2018 - PR Newswire
Board and Executive Moves-Financial Results

 Intec Pharma LTD (NASDAQ: NTEC) (TASE: NTEC) today announces financial results for the three and twelve months ended December 31, 2017 and provides a corporate update.

"The past quarter capped what continues to be a transformational time for Intec Pharma.  We made significant progress expanding our clinical and regulatory teams while advancing our clinical development programs. We continue to focus on execution of the ACCORDANCE Trial, our pivotal Phase 3 trial in Parkinson's Disease. ...